You are on page 1of 9

INTRODUCTION TO PHARMACEUTICAL

ANALYSIS 2 AND QUALITY ASSURANCE


a. raw materials – or unprocessed
materials
b. defects – undesirable characteristics
of a product
c. sampling – the act of getting a
representative from the entire population
d. risk - a situation involving exposure to danger

What is quality? QUALITY ASSURANCE vs. QUALITY CONTROL


Quality means differently to different people.
QUALITY ASSURANCE
a. MARKETING It is the sum total of organized arrangements
 quality means better performance, nicer made with the object of ensuring that product
features, other improvements (sometimes will be of quality required by their intended use.
costly)
 It includes all those planned or systematic
b. MANUFACTURING
actions necessary to provide adequate
 conforming to standards and “making it right
confidence that a product will satisfy the
the first time”
requirements for faculty.
c. The American Society for Quality
 “The totality of features and characteristics  Its approach is company-based.
of a product or service that bears on its ability It is responsible for ensuring that the
to satisfy implied or stated needs.” quality policies adopted by the company
are followed.
Three Pillars of Drug Products:  Its functions includes monitoring of
1. Safety environmental conditions.
2. Efficacy
3. Quality Quality Control

 It is the part of GMP which is concerned


Governing Bodies: with sampling, specifications, testing and
1. FDA – Food and Drug Administration within organization, documentation, and
2. cGMP – current Good Manufacturing release procedures which ensure that the
Practices necessary and relevant tests are carried
out.
It includes operational laboratory
techniques and activities used to fulfill the
requirement of quality.
Its approach is laboratory-based.
It is responsible for the day-to-day control
of quality within a company.
Its functions includes quality monitoring
and audit function.

The aspects of quality assurance.


 sampling, specifications and testing as well as
the organization, documentation and release
procedures, which ensure that the necessary
and relevant tests are actually carried out and
that materials are not released for use, nor
products released for sale or supply, until their
quality has been judged to be satisfactory.

Things to consider:
1. It must be staffed with persons who are
trained academically and is capable of
evaluating the acceptability of material tested.
QA Departmental Functions 2. Equipment and instrumentation must be
1. Assures policies are followed inept to suitable in an accurate and efficient manner.
economic issues associated with manufacturing 3. Detailed specifications must be available, as
and distribution of product well as validated test methods.
2. Cooperate with regulatory agencies and final 4. Procedures must be validated and strictly
authority for product acceptance or rejection followed.
3. Helps to identify and prepare necessary SOP’s Quality Management System
relative to control of quality  This quality objective is the responsibility of
4. Audit and quality monitoring senior management and requires the
QC Functions participation and commitment by staff in many
1. Testing and acceptance of only highly quality different departments and at all levels within
raw material, representative samples the company, by the company’s suppliers and
2. IP tests against criteria by the distributors.
3. Monitors environmental conditions 1. All parts of the Quality Assurance systems
4. Control packaging components should be adequately resourced with
3 Main Areas of QC: competent personnel, and suitable and
1. Raw Material Quality Control (RMQC) sufficient premises, equipment and facilities.
2. In Process Quality Control (IPQC) 2. It assures that the holder of a manufacturing
3. Finished Product Quality Control (FPQC) authorization must manufacture medicinal
Terms to be defined: products so as to ensure that they are fit for
1. Monograph - Document that specifies all the their intended use, comply with the
tests to be conducted on a product and/or requirements of the Marketing Authorization
appropriate references containing details of and do not place patients at risk due to
procedure and expected result inadequate safety, quality or efficacy.
2. Certificate of Analysis (COA) - Document with 3. Fully documented and its effectiveness
the results of all tests conducted on material to monitored.
show compliance or non-compliance with the cGMP
standard specifications  current Good Manufacturing Practice
3. Formula - This is concise and precise  concerned with both production and quality
statement of the ingredients that comprise the control
product, together with the percentage and/or  the part of QA which ensures products are
weight of each. consistently produced and controlled to the
4. Standard Operating Procedures (SOP) - This is quality standards appropriate for their intended
a step by step method on how to go about a use
job.
5. Sample – a representative obtained from a March 1979
certain population - the FDA issued revised GMP regulations
which presents the minimum requirements to
be met by industry when manufacturing,
QUALITY CONTROL packaging, and holding human and veterinary
products in all aspects of products and services that are
important to the customer
Why follow GMP regulations?  combined team effort to develop, produce,
Some of the main risks are: market, distribute, and control products that
1. unexpected contamination of products, are safe and effective
causing damage to health or even death.
2. incorrect labels on containers, which could 1. Quality must be designed into products.
mean that patients receive the wrong medicine. a. product quality criteria are established
3. insufficient or too much active ingredient, b. detailed specifications are written
resulting in ineffective treatment or adverse c. written procedures must be prepared
effects. d. processes must be validated
Quality Risk Management e. raw materials must provide products of
 a systematic process for the assessment, uniformly high quality
control, communication and review of risks to f. facilities must provide the proper stable
the quality of the medicinal product. It can be environment
applied both proactively and retrospectively. g. equipment must prevent cross-
contamination
h. personnel must be trained properly
2. Distribution department  responsible for
controlling the shipping and handling of
products (inventory system and FIFO/FEFO)
3. Marketing Department  must be sensitive
to the customer’s needs and be responsive to
complaints
4. QA/QC Department  gives approval if all of
the aspects of GMP have been satisfied

The quality risk management system should


ensure that:
- the evaluation of the risk to quality is
based on scientific knowledge, experience with
the process and ultimately links to the
protection of the patient
- the level of effort, formality and
documentation of the quality risk management
process is commensurate with the level of risk
Total Quality Management
 or Total Product Management
The eight elements of TQM.
 improves productivity and customer
satisfaction
 refers to a quality emphasis that
encompasses the entire organization from top
management to rank and file
 stresses a commitment by management to
have a company wide drive towards excellence
QUALITY CONTROL 2. It guarantees conformance to regulatory
requirements.
he key features of any laboratory QC system are 3. It guarantees product efficacy.
that the system is documented, understood, 4. It reduces operating costs.
stable, reliable and supports continuous 5. It reduces operating losses.
quality improvement. The laboratory must be 6. It produces higher employee morale.
able to demonstrate that there is a ‘system’ in 7. It motivates the pharmaceutical/medical
place and not just a series of unco-ordinated professionals to sell or prescribe the product.
activities. These activities must be subject to
audit (external and internal) and review
(Badrick, 2008).

The foundation for a successful Quality


Assurance program is the quality control
maintained by the Producer to assure that all
materials submitted for acceptance conform to
the contract requirements. To accomplish this,
the Producer is required to have a functional
plan to keep the process in control, quickly
determine when the process goes out of
control, and respond adequately to bring the
process back into control.

a. cGMP – means current Good


Manufacturing Practices The umbrella of quality.
b. specifications - a detailed description Standards and specifications
of the design and materials used to make  developed to serve as a basis for accepting or
something rejecting a product to avoid producing a
c. sterile – free from any contamination defective product

Manufacturing firm 1. Formula – concise and precise statement of


 recognized as a major industry which the raw materials with percentage and/or
requires a clearly defined organization and weight of each
effective coordination; towards the production 2. Raw Material Specification – characteristics
of a drug or cosmetic of the highest standard and permissible range of purity
and at the lowest cost 3. Standard Operating Procedure – all
 must be done in compliance with cGMP (AO information and instructions to assure that
No. 220, s 1974) variations will be held within acceptable
established ranges
Common Divisions in a Manufacturing Firm 4. Finished Product Specification – all
(under a general manager): characteristics
1. Finance 5. Packaging Material Standard – set for
2. Production everything that goes around the product
3. Quality Assurance (Quality Control) a. The units may have to run on a high-
4. Marketing (optional) speed line.
QUALITY CONTROL b. The may involve a complicated
 enforces cGMP assembly.
 organized to be the core of the company’s c. The package may be functional.
quality audit program d. The package must be completely
 a tool which gives the assurance that a compatible with the product.
product conforms to standards and e. The package must protect the
specifications through a system of inspection, product and assure its stability.
analysis and action f. The package must ship well.
Quality control system 6. Testing Methods – must be standardized and
Potential Benefits: validated to ensure precision and accuracy on
1. The system minimizes or eliminates the risk application
of marketing unsafe products.
DEFECTS 2. To sample and conduct physical tests on:
 an undesirable characteristic of a product a. All shipments of packaging materials
 a failure to conform to specifications b. All manufacturing, filling and
packaging operations
1. According to MEASURABILITY: 3. To maintain periodic examination on the
a. Variable defect – can be measured directly quality of inventories throughout all phases of
by instruments storage, shipping and distribution.
b. Attribute defect – cannot be measured 4. To perform an audit which is independent of
directly by instruments the work done by production personnel.
2. According to SERIOUSNESS or GRAVITY: Analytical Laboratory
a. Critical defect – may endanger the life or  should be in an accessible area and
property and may render the product non- protected from noise and vibration
functional  performs physical and chemical
b. Major defect – may affect the function of analysis
the object and may render the product useless Biological Testing Laboratory
c. Minor defect – does not endanger life or  provides sterile conditions,
property nor will affect the function precludes noise
3. According to NATURE: 1. To performs and evaluate microbiological and
a. Ocular defect – visible defect pharmacological assays, sterility, pyrogen and
b. Internal defect – not seen although bacteriological tests, irritation, safety or acute
present toxicity tests.
c. Performance defect – a defect in function 2. To conduct environmental monitoring.
Sources and control of quality variation
1. Materials
a. Variation between suppliers of same Specifications and Analytical Development
substance. 1. To coordinate with research, product
b. Variation between batches from development, production, sales and
same supplier. management towards improvement of a
c. Variation within a batch. product.
2. Machines 2. To establish specifications for raw and
a. Variation of equipment for the same packaging materials.
process. 3. To validate existing and tentative procedures
b. Difference in adjustment of of testing.
equipment. 4. To establish specifications based on validated
c. Aging and improper care. procedures.
3. Methods 5. To develop new assay methods for in-house
a. Inexact procedures. use.
b. Inadequate procedures. 6. To develop and improve specifications for
c. Negligence by chance. quality characteristics of the final product being
4. Men manufactured.
a. Improper working conditions. Quality Coordination Office
b. Inadequate training, and  main responsibility is
understanding. documentation
c. Dishonesty, fatigue and carelessness. 1. To maintain and store records that represent
the history of the batch from start to finish
ORGANIZATION OF QUALITY CONTROL (batch and master formula records, raw
Quality Control Manager material analytical records, printed and
 Material Inspection Section packaging material inspection reports and
 Analytical Laboratory retention files).
 Biological Testing Laboratory 2. To be able to furnish data that will aid in
 Specifications and Analytical analyzing product performance in the market
Development (stability studies and returned goods reports).
 Quality Coordinating Office 3. To investigate customer complaints or
Materials Inspection Section inquiries on product quality and to forward the
1. To sample and examine all raw materials results of the investigations in the form of
received. technical reports to the sales organization.
4. To call the attention of the appropriate
development group regarding any aspect that
provides a basis for improvement of a product
for consideration and action.
5. To provide data that give scientific and legal
status (function of the distribution section or
warehouse).
6. To maintain and develop SOP’s.
CONTROL FUNCTIONS
1. ANALYSIS FUNCTION
 made on:
a. raw materials and packaging
components
b. bulk products during processing and
after packaging prior to its release to the market
c. finished products after distribution
to the end user subjected to shelf life studies
d. product against a complaint
2. MONITOR FUNCTION
a. to sample and examine materials while
they are being processed
b. to do environmental monitoring on a
time basis
3. RECORD REVIEW AND RELEASE FUNCTION
 responsible for carefully reviewing the batch
record for a specific lot and assuring that all
necessary records are present, complete and
accurate (if feasible to determine)
4. AUDIT FUNCTION
 designed to detect areas where the
established SOP’s are not being followed and to
report these findings to the supervisor for
appropriate action

COMPENDIAL REQUIREMENTS FOR SOLID AND


SEMI-SOLID DOSAGE FORMS - aka TOLUENE or XYLENE METHOD
- also used in ALCOHOL CONTENT
a. titrimetry - refers to a group of DETERMINATION
methods of quantitative analysis in which an c. Method III (Gravimetry)
analyte is determined basing on its - preferred for articles from botanical origin
stoichiometric reaction with a reagent of - Apparatus: Ohaus Moisture-Balance Analyzer
established concentration introduced to a
sample gradually until the analyte is consumed
quantitatively
b. gravimetry - used where weights of reactants
and products of chemical reactions are
reproducible, stable and reflect the presence of
constituents which are important in the
establishment of identity

IN-PROCESS QUALITY CONTROL


 IPQC is concerned with providing
accurate, specific, & definite
descriptions of the procedures to be Apparatus used to determine the moisture
employed, from, the receipt of raw content of powders or granules.
materials to the release of the finished 2. Adequacy of Wetness
dosage forms. - Final Moisture Content: 0.5 - 1.0%
 In process Quality Control, IPQC tests 3. Particle Size Determination
are mostly performed within the a. Optical microscopy - most reliable
production area. b. Sieve analysis - fastest
 They should not carry any risk for the - LIMITATIONS:
quality of product. large sample size needed (NLT 25g)
 In process testing enables easier not for oily/cohesive materials
identification of problems. It sometime - APPARATUS: set of sieves with varying mesh
identifies a defective product batch number
that can be corrected by rework, increase in sieve no. = decrease in particle size
whereas once that batch has been SIEVING METHOD: Mechanical Agitation/Dry
completed, this may not be possible. Sieving – >75μm particles
 Failure to meet in process control Air jet sieving – single sieve
specification indicates either that Sonic sifter sieving – nest of sieves
procedure were not followed or some
factor (S) out of control.

A. SOLID DOSAGE FORMS IPQC PROCEDURES


I. Granules and Powders
1. Initial Moisture Content
- Wet Granulation
- Acceptance Limit: 31-35%
- Methods:
a. Method I (Karl-Fischer
Titrimetry)
Karl-Fischer Reagent – 1mL
KFR = 15mg water
Components: SO2, iodine,
pyridine, anhydrous methanol
Types:
Method Ia (direct) Set-up for sieving analysis.
Method Ib (residual) - ENDPOINT DETERMINATION: If ≥5% of sample
Method Ic (coulometric) weight is present on a sieve, % weight change is
NMT 5%.
b. Method II (Azeotropic Distilation)
If <5% of sample weight is present on a sieve, %
weight change is NMT 20%
-FORMULA:

4. Density
a. Bulk Density – ratio of mass of an
untapped sample and its volume, including its
interparticulate void volume
METHODS:
Graduated Cylinder (I)
Volumeter (II) – Scott Volumeter
Vessel (III) – 100 mL stainless steel cylindrical
vessel
Method 1 of determining the powder’s bulk
density. b. Hausner Ratio and Carr’s (Compressibility)
Index- measures of a powder’s ability to settle
b. Tapped Density – an increased bulk density
attained after tapping a powder/granule sample
METHODS:
Method I and II
i. Tap 10 times (V10)
ii. Tap 500 times (V500)
iii. Tap 1,250 times (V1250)
iv. Determine the tapped volume
 If V500 – V1250 ≤ 2mL, V1250 = tapped volume
 If V500 – V1250 > 2mL, repeat in increments of
1,250 taps until difference is < 2mL.
Method III
i. 50-60 taps/min
ii. 200 taps
iii. 400 taps

5. Powder Flow
a. Angle of Repose - constant 3D angle
(relative to horizontal base) assumed by a cone- c. Flow Through Orifice- measured as mass per
like pile of material time flowing from any container
APPARATUS: Fixed Funnel, d. Shear Cell
Tilting Box, Revolving Cylinder 6. Loss on Drying  amount of volatile matter
driven off; 110-120°C

7. Content Uniformity
- acceptance criteria: + 2% of active component
98% - 102%

II. Tablets
1. Tablet Hardness  measure of a tablet’s
resistance to mechanical shocks
 affects friability, disintegration and
dissolution
 “rule of thumb”
- UNIT: Kg
- HARDNESS TESTERS:
a. Stokes-Monsanto – uses a barrel with
compressible spring applied diametrically to a thickness x 0.05)
tablet Lower Limit = specified thickness - (specified
thickness x 0.05)
3. Tablet Weight  unofficial test based on USP
XX
- STEPS:
A Stokes Monsanto tablet hardness tester. i. Get 20 tablets.
b. Strong-Cobb – force produced by a manually ii. Weight individually.
operated air pump iii. Compute for average tablet weight.
iv. Determine acceptable % variation.

v. Compute for acceptable


tablet weight range.
- ACCEPTANCE CRITERIA:
a. NMT ≥ 2 tablets are outside acceptable tablet
weight range.
b. No unit is outside twice acceptable %
variation.
Strong cobb tablet hardness tester.
c. Pfizer – makes use of hand pliers as aid
Pfizer-type tablet hardness tester.
d. Erweka – use of suspended weight

Erweka tablet hardness tester.


f. Schleuniger – most common; motorized anvil;
horizontally position
- CRITERIA:
Compressed Uncoated Tablets – 4-10 kg
Buccal Tablets – 7-10 kg
Chewable/Sublingual Tablets – 2-3 kg

. Tablet Thickness  for consumer acceptance


 facilitates packaging
- APPARATUS: Vernier Caliper

Parts of Vernier caliper, apparatus used to


measure tablet thickness.
CRITERIA: +/- 5% of specifications
Upper Limit = specified thickness + (specified

You might also like